BTAIVSNNNN• 6 Months (Normalized)
BTAI vs NNNN (BioXcel Therapeutics Inc. vs Anbio Biotechnology)
Showing Closing Date Range from Mar, 15 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.05
-96.69%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
NNNN Performance $6.34
-70.94%
Anbio Biotechnology
Normalized Baseline0.00%
Alpha Spread Margin NNNN LEADS
-25.75%
NNNN outperforming by 25.75%
BTAINNNN
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI NNNN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(125 dates)
| Date | BTAI Price | BTAI Gain (%) | NNNN Price | NNNN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $0.05 | -96.69% | $6.34 | -70.94% | -25.75% |
| Sep 10, 2026 | $0.05 | -96.75% | $6.51 | -70.16% | -26.59% |
| Sep 09, 2026 | $0.05 | -96.95% | $6.47 | -70.35% | -26.60% |
| Sep 08, 2026 | $0.04 | -97.21% | $6.48 | -70.30% | -26.91% |
| Sep 04, 2026 | $0.07 | -95.19% | $6.54 | -70.03% | -25.16% |
| Sep 03, 2026 | $0.12 | -92.34% | $6.60 | -69.75% | -22.59% |
| Sep 02, 2026 | $0.11 | -93.05% | $6.85 | -68.61% | -24.44% |
| Sep 01, 2026 | $0.14 | -91.10% | $7.22 | -66.91% | -24.19% |
| Aug 31, 2026 | $0.16 | -89.42% | $7.30 | -66.54% | -22.88% |
| Aug 28, 2026 | $0.18 | -88.25% | $7.67 | -64.85% | -23.40% |
| Aug 27, 2026 | $0.72 | -53.31% | $7.78 | -64.34% | +11.03% |
| Aug 26, 2026 | $0.78 | -49.35% | $7.72 | -64.62% | +15.27% |
| Aug 25, 2026 | $0.74 | -51.82% | $7.83 | -64.12% | +12.30% |
| Aug 24, 2026 | $0.76 | -50.58% | $7.90 | -63.79% | +13.21% |
| Aug 21, 2026 | $0.80 | -47.79% | $6.81 | -68.79% | +21.00% |
Page 1 of 9